/ WHAT YOU WILL RECEIVE
Real photographs of your peptides, boxed, lot-labeled, and shipped in plain unmarked packaging from our partner research lab.
More batch photos and lab footage coming soon.
⏱ HALF-LIFE · PHARMACOKINETIC PROFILE
Combined LH + FSH (1:1) gonadotropin
~12 to 24 hours
Both LH and FSH activity · supports HPTA / fertility research where hCG alone is insufficient.
HGH & Ancillaries · RESEARCH GRADE
HMG (Human Menopausal Gonadotropin)
75 IU · Lyophilized Vial
Combined LH + FSH activity, 75 IU research vial for HPTA recovery and fertility protocols.
UNIT PRICE
$35 USD
≈ CA$48
≈ $0.47 per IU · 75 IU total
Reconstitution required
This compound requires bacteriostatic water for reconstitution. Don't forget to add a 10mL vial of BAC water to your order, available in Lab Supplies.
HOW LONG WILL IT LAST YOU?
Enter your research protocol and vial quantity — see exactly how many weeks your order covers.
Each 75 IU vial lasts
3.5 days
Your 75 IU vial lasts
3.5days
≈ 4 days · 1.0 doses per vial
FOR RESEARCH USE ONLY
Not for human consumption. Intended for laboratory and in-vitro research applications./ RESEARCH DOSSIER
Everything we know
about HMG.
Direct from the research literature. Every section is sourced from peer-reviewed peptide studies and clearly labelled when effects come from animal or cell-line models.
/ 01 · WHAT WE KNOW
The background.
Human Menopausal Gonadotropin (Menotropin) is a purified preparation of two glycoprotein gonadotropins, Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), typically extracted from the urine of post-menopausal women in an approximately 1:1 ratio. Unlike hCG (which only mimics LH activity), HMG delivers BOTH testicular signaling pathways: LH drives Leydig-cell testosterone production, while FSH drives Sertoli-cell spermatogenesis.
/ 02 · WHAT IT DOES FOR YOU
What researchers study it for.
Researchers study HMG primarily for two endpoints: (1) HPTA (hypothalamic-pituitary-testicular axis) recovery and testicular volume restoration during or after exogenous androgen administration, where hCG alone often fails to recover spermatogenesis because it bypasses FSH signaling, and (2) male / female fertility protocols where both follicular development and ovulation/spermatogenesis support are required.
/ 06 · DOSAGE & RECONSTITUTION
Research dosing protocols.
Common research protocols: • HPTA / fertility maintenance on TRT or AAS: 75 to 150 IU 2 to 3× per week, subcutaneously, often alongside 250 to 500 IU hCG 2× per week. • Post-cycle fertility recovery: 75 to 150 IU every other day for 2 to 4 weeks, then taper. • Fertility-only protocols: 75 to 225 IU daily until follicular / spermatogenic endpoints are met (typically 2 to 6 weeks). Always reconstitute with bacteriostatic water immediately before use; HMG is a purified protein and degrades rapidly in solution, refrigerate (2 to 8 °C) and use within 14 to 28 days of reconstitution.
/ 07 · PAIRS WELL WITH
Researched stacks.
Compounds explored alongside HMG in the published literature.
HMG + hCG (combined gonadotropin protocol)
Many on-cycle and post-cycle research protocols pair low-dose hCG (LH-mimetic) with HMG (LH+FSH) to maintain BOTH testicular size AND fertility during exogenous androgen use. hCG keeps Leydig cells active; HMG adds FSH stimulation that hCG alone can't provide.